中财网 中财网股票行情
拓新药业(301089)财务分析指标    年份：
截止日期2025-09-302025-06-302025-03-312024-12-312024-09-30
营业总收入(万元)27155.3618189.989699.4742169.4132575.37
营业收入(万元)27155.3618189.989699.4742169.4132575.37
营业总成本(万元)31578.3320228.3710416.7645944.1034630.37
营业成本(万元)19182.2012512.676725.8429574.6624207.77
净利润(万元)-3016.11-1828.05-356.47-1911.57-265.38
归属于母公司的净利润(万元)-3016.11-1828.05-356.47-1988.49-265.38
营业利润(万元)-3635.82-2105.58-373.45-2371.82-714.88
利润总额(万元)-3650.96-2143.13-396.83-2773.25-1089.72
少数股东损益(万元)----------
基本每股收益(元)-0.24(元)-0.14(元)-0.03(元)-0.16(元)-0.02(元)
稀释每股收益(元)-0.24(元)-0.14(元)-0.03(元)-0.16(元)-0.02(元)
非经常性损益(万元)578.18--238.79737.05768.82
扣除非经常性损益后净利润(万元)-3594.28-2220.76-595.27-2725.54-1034.19
总资产(万元)168936.52170723.00175169.37175824.39174658.97
总负债(万元)16700.6217299.0520273.8420572.3917760.77
归属于母公司股东权益合计(万元)152235.90153423.95154895.53155252.01156898.20
股东权益合计(万元)152235.90153423.95154895.53155252.01156898.20
实收资本(股本)(万元)12654.4512654.4512654.4512654.4512654.45
资本公积(万元)62111.0062111.0062111.0062111.0062111.00
未分配利润(万元)70727.2071915.2673386.8473743.3175466.42
经营活动产生的现金流量净额(万元)-2278.96-2301.46-2801.0510266.8710912.89
经营活动现金流入小计(万元)24574.2016104.687406.3641806.9936398.43
经营活动现金流出小计(万元)26853.1618406.1410207.4231540.1225485.54
投资活动产生的现金流量净额(万元)2434.031898.1211124.24-13987.61-1408.75
投资活动现金流入小计(万元)72891.1647257.8834188.7361403.6246314.68
投资活动现金流出小计(万元)70457.1345359.7623064.4975391.2347723.43
筹资活动产生的现金流量净额(万元)-122.42-----3257.29-3154.46
筹资活动现金流入小计(万元)--------9.15
筹资活动现金流出小计(万元)122.42----3257.293163.61
期末现金及现金等价物余额(万元)6195.395787.9914519.726178.1719429.19
最后修改日期2025-10-292025-08-272025-04-292025-04-292024-10-29
↑返回页顶↑

转至拓新药业（301089）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。